BME:PHMBiotechs
Pharma Mar (BME:PHM) Valuation Check After New Globant AI Partnership In Cancer Drug Discovery
Pharma Mar (BME:PHM) has drawn fresh attention after partnering with Globant to deploy a multi agent AI platform designed to support faster, more accurate cancer drug discovery across its research and development operations.
See our latest analysis for Pharma Mar.
The latest €86.45 share price comes after a 15.81% 90 day share price return and a 7.73% 30 day share price return. The 3 year total shareholder return of 108.30% contrasts with a 6.47% decline over five years, suggesting momentum...